yes they are. I quoted that for possible funding down the track...

yes they are. I quoted that for possible funding down the track just like the 3.5c options will be. our current applications, were applied for in the middle of last year. from oct 4c



several separate gov't grants, with the qld gov't split into 2, 800/1000 cycles. it's just one possible source of funds


before the end of the year. ev1 will have locked in it's design freeze. consumer electronic 1 should have hit their 800 cycle threshold. plus several other milestones from the graphic I posted earlier. what could the sp be then and would another raise cause less dilution than the 3.5c options.

plus the chance of increasing revenue. serum institute of india plus other life science companies who are currently testing anteobind NXT. also revenue from anteoX.



we sold ev1 $60k worth in dec. we have 10 partners with - " future supply of larger volumes to current partners"

anteotech claims it with every announcement "revenue stage company" "first revenues targeted in 2024"


all factors to consider when voting. IMO...